retatrutide ly3437943 triple agonist glp-1 gip glucagon Eli Lilly just announced striking Phase 3 results for retatrutide, an experimental “triple agonist” that acts on three gut-hormone targets at once. On the top dose, people lost an average of 28% Retatrutide the wonder drug: What's

This face wash removes impurities while leaving your skin smooth, refreshed, and radiant

NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease

The Syntha-Pep serum is supplied in a sealed cartridge that interfaces directly with the needle head

Even tried fecal microbial transplant, which was preceded by a barrage of numerous oral antibiotics of virtually every class, followed by a night long laxative gut-prep as is done prior to a colonoscopy, then introducing the inoculant (donor feces) with a very long tube, to get it well up into the colon, once a day for a week

These include vomiting, nausea, and diarrhea

Shared pathomechanisms of neuropsychiatric syndromes with fatigue as a leading symptom (PASC, PAIS, ME/CFS, IMD) Alterations of brain structure and connectivity PASC is currently being investigated by neuroimaging experts all over the world